08037.HK
China Biotech Services Holdings Limited
HKSE · Healthcare · Medical - Diagnostics & Research · HK
HKD 0.60
+0.00%Margins
Gross margin
10.5%
EBITDA margin
-81.2%
EBIT margin
-103.2%
Net margin
-93.6%
FCF margin
-267.5%
-31.8%
Return on equity
-8.4%
Return on assets
-11.2%
Return on invested capital
0.10x
Asset turnover
-HKD 54.5M
Cash from operations
HKD 0.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026